To develop a model to predict disease progression in a large cohort of patients across a variety of neurodegenerative diseases, including Mild Cognitive Impairment (MCI) and dementia due to any neurodegenerative disease, including Alzheimer's Disease (AD), Lewy Body Disease (LBD), Vascular Disease (VaD) and Frontotemporal lobar degeneration (FTLD).
The goal of this study is to create a model to predict disease progression in patients with mild cognitive impairments and forms of dementia. To accomplish this, the current study will evaluate different tests including: brain imaging (MRI), body fluid samples (blood and cerebrospinal fluid), skin biopsy, cognitive ability, and behavioural questionnaires. The study team hopes that this information can be used to guide diagnosis and better predict disease progression in patients with mild cognitive impairment and and early dementia.
Study Type
OBSERVATIONAL
Enrollment
500
Baycrest
North York, Ontario, Canada
NOT_YET_RECRUITINGSunnybrook Health Sciences Centre
Toronto, Ontario, Canada
NOT_YET_RECRUITINGToronto Western Hospital, University Health Network
Toronto, Ontario, Canada
RECRUITINGCentre for Addiction and Mental Health
Toronto, Ontario, Canada
NOT_YET_RECRUITINGCognitive phenotype
Change in Toronto Cognitive Assessment (TorCA) scores out of 330, where lower scores indicate increasing cognitive impairments, and individual domains.
Time frame: Baseline, 6-month follow-up, 1-year follow-up
Assessment of DNA methylation (DNAm) from bloodwork
Biological age from DNA methylation (DNAm) collected via bloodwork compared to chronological age.
Time frame: Baseline
Neurodegenerative protein levels in biofluids and skin biopsy
Differences in protein levels between neurodegenerative diagnoses and predictive ability for change in TorCA
Time frame: Baseline, 6-month follow-up, 1-year follow-up
Structural and Functional Differences between neurodegenerative diseases via MRI of the brain
Brain volumes and white matter hyperintensity (WMH) load corresponding to Toronto Cognitive Assessment (TorCA) scores out of 330 where lower scores indicate increasing cognitive impairments.
Time frame: Baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.